{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260629433290/en/Genmab-Announces-Positive-Phase-3-Results-for-Epcoritamab-Plus-Lenalidomide-in-Patients-with-RelapsedRefractory-Diffuse-Large-B-Cell-Lymphoma-Demonstrating-Statistically-Significant-Improvement-in-Progression-Free-Survival", "message": "News view counter 821269 successfully enlarged"}